Jump to navigation
Neil Vigil, a student in the Class of 2021 at the UA College of Medicine — Phoenix, was selected for the prestigious scholarship based on his military service and leadership.
The UA has met or surpassed expectations in technology commercialization for the fiscal year 2018, as Tech Launch Arizona continues to enhance the impact of UA research for the public.
Ketamine, a drug currently used to treat pain and depression, is being repurposed to potentially help Parkinson’s patients in a new clinical trial at the UA College of Medicine – Tucson.
Five colleges at the University of Arizona are studying human and environmental risks and developing practical solutions for the mining industry and health professions.
Jerome Lacombe and other University of Arizona researchers are hoping to improve upon traditional radiation testing methods through gene expression.
Lifelong cytomegalovirus infection may be beneficial, boosting the immune system in old age, when we need it most, according to a study led by UA researchers.
Dr. Irving L. Kron joins the University of Arizona Health Sciences senior leadership team from the University of Virginia, where he was chairman of the department of surgery.
Tucson's newest early-stage capital fund, UA Venture Capital Fund LLC, has announced that its first three investments will include UA-connected companies Codelucida and Regulonix.
UA College of Medicine – Phoenix scientists, including "organ on a chip" pioneer Frederic Zenhausern, are using plant biology, medicine and engineering to create a novel platform.
Inventors at the UA College of Medicine – Tucson and Banner – University Medical Center Tucson are working with Tech Launch Arizona on a next-generation instrument.